Replies to post #560677 on $Stock*Shop*Charts*News*Option$

[dDT]

Valeant initiates debt offering

Valeant Pharmaceuticals (NYSE:VRX) commences a private offering of $9.6B aggregate principal amount of senior unsecured notes. The debt, together with the company's incremental term loan facilities and cash on hand, will fund the acquisition of Salix Pharmaceuticals (NASDAQ:SLXP).